CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 109 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $160,481,000 | +6.3% | 1,418,925 | -5.9% | 0.01% | +12.5% |
Q1 2017 | $151,007,000 | +639.5% | 1,508,096 | +694.1% | 0.01% | -72.4% |
Q4 2016 | $20,420,000 | +47.1% | 189,913 | +70.3% | 0.03% | +45.0% |
Q3 2016 | $13,884,000 | +22.6% | 111,538 | +4.7% | 0.02% | +17.6% |
Q2 2016 | $11,328,000 | -18.9% | 106,539 | -12.6% | 0.02% | -22.7% |
Q1 2016 | $13,962,000 | -17.8% | 121,955 | +2.3% | 0.02% | -12.0% |
Q4 2015 | $16,987,000 | +79.2% | 119,238 | +13.0% | 0.02% | +66.7% |
Q3 2015 | $9,478,000 | -48.6% | 105,511 | -34.1% | 0.02% | -44.4% |
Q2 2015 | $18,431,000 | – | 160,044 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WARBURG PINCUS LLC | 8,344,200 | $960,918,000 | 7.67% |
RUDMAN ERROL M | 130,201 | $14,994,000 | 5.06% |
Ativo Capital Management LLC | 59,101 | $7,258,000 | 2.56% |
Kylin Management | 188,226 | $21,676,000 | 2.36% |
Monashee Investment Management LLC | 40,000 | $4,606,000 | 2.17% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 62,866 | $7,240,000 | 1.91% |
Cormorant Asset Management, LP | 111,500 | $12,840,000 | 1.71% |
OBERWEIS ASSET MANAGEMENT INC/ | 53,500 | $6,161,000 | 1.63% |
Perceptive Advisors | 147,604 | $16,998,000 | 1.02% |
Granite Point Capital Management, L.P. | 29,160 | $3,358,000 | 0.98% |